Integral Health Asset Management, LLC Abb Vie Inc. Transaction History

Integral Health Asset Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $5.59 Million - $6.37 Million	-35,000 Reduced 20.59%	135,000 $24.6 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $23.4 Million - $26.3 Million	170,000 New	170,000 $26.3 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $2.52 Million - $3.13 Million	19,000 Added 23.46%	100,000 $13.5 Million
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $4.48 Million - $5.16 Million	31,000 Added 62.0%	81,000 $12.9 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $6.92 Million - $8.29 Million	50,000 New	50,000 $8.09 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $6.6 Million - $8.19 Million	-50,000 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $1.61 Million - $2.04 Million	15,000 Added 42.86%	50,000 $6.77 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $3.72 Million - $4.23 Million	35,000 New	35,000 $3.78 Million
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $7.16 Million - $7.88 Million	-70,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $5.63 Million - $7.61 Million	70,000 New	70,000 $7.5 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $2.15 Million - $2.52 Million	-25,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $1.83 Million - $2.45 Million	25,000 New	25,000 $2.46 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $6.13 Million - $9.29 Million	-95,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $6.85 Million - $8.57 Million	95,000 New	95,000 $8.41 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.